Clinical Trial Update: Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports that aspirin may improve survival in patients with advanced nasopharyngeal carcinoma (N2-3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN